These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22267862)

  • 21. Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia.
    Schmidtke K; Hüll M
    J Neurol Sci; 2002 Nov; 203-204():17-22. PubMed ID: 12417351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND).
    Stephan BCM; Minett T; Muniz-Terrera G; Harrison SL; Matthews FE; Brayne C
    Age Ageing; 2017 Sep; 46(5):755-760. PubMed ID: 28203692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified cerebral small vessel disease score is associated with vascular cognitive impairment after lacunar stroke.
    Zhi N; Zhang L; Wang Y; Bai S; Geng J; Yu L; Cao W; Zhuang L; Zhou Y; Guan Y
    Aging (Albany NY); 2021 Feb; 13(7):9510-9521. PubMed ID: 33535189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep microbleeds and periventricular white matter disintegrity are independent predictors of attention/executive dysfunction in non-dementia patients with small vessel disease.
    Cao WW; Wang Y; Dong Q; Chen X; Li YS; Zhou Y; Gao L; Deng Y; Xu Q
    Int Psychogeriatr; 2017 May; 29(5):793-803. PubMed ID: 27938433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Korean Addenbrooke's Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer's disease and subcortical ischemic vascular dementia.
    Kwak YT; Yang Y; Kim GW
    Geriatr Gerontol Int; 2010 Oct; 10(4):295-301. PubMed ID: 20497240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cumulative effect of small vessel disease lesions is reflected in structural brain networks of memory clinic patients.
    Heinen R; Vlegels N; de Bresser J; Leemans A; Biessels GJ; Reijmer YD;
    Neuroimage Clin; 2018; 19():963-969. PubMed ID: 30003033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
    Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
    J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impact of cerebral microbleeds in patients with symptomatic small vessel disease.
    Nannoni S; Ohlmeier L; Brown RB; Morris RG; MacKinnon AD; Markus HS;
    Int J Stroke; 2022 Apr; 17(4):415-424. PubMed ID: 33877017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of the K-T cancellation test in a memory clinic population.
    Wu YH; de Rotrou J; Sikkes SA; Rigaud AS; Plichart M
    J Clin Exp Neuropsychol; 2016 Dec; 38(10):1094-102. PubMed ID: 27349139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COST: Cognitive State Test, a brief screening battery for Alzheimer disease in illiterate and literate patients.
    Babacan-Yildiz G; Isik AT; Ur E; Aydemir E; Ertas C; Cebi M; Soysal P; Gursoy E; Kolukisa M; Kocaman G; Celebi A
    Int Psychogeriatr; 2013 Mar; 25(3):403-12. PubMed ID: 23137551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive screening instruments to identify vascular cognitive impairment: A systematic review.
    Ghafar MZAA; Miptah HN; O'Caoimh R
    Int J Geriatr Psychiatry; 2019 Aug; 34(8):1114-1127. PubMed ID: 31050033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verbal fluency in cerebral small vessel disease and Alzheimer's disease.
    Herbert V; Brookes RL; Markus HS; Morris RG
    J Int Neuropsychol Soc; 2014 Apr; 20(4):413-21. PubMed ID: 24589176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Study of Risk Factors and Cognitive Profile of Small- and Large-Vessel Vascular Dementia - A Clinic Based Study.
    Bhat A; Das G; Mukherjee A; Mukherjee D; Gangopadhyay G; Biswas A
    Neurol India; 2022; 70(1):258-263. PubMed ID: 35263892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.
    Moorhouse P; Song X; Rockwood K; Black S; Kertesz A; Gauthier S; Feldman H;
    J Neurol Sci; 2010 Jan; 288(1-2):142-6. PubMed ID: 19840883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trajectories of cognitive decline in different types of dementia.
    Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM
    Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The INECO Frontal Screening for the Evaluation of Executive Dysfunction in Cerebral Small Vessel Disease: Evidence from Quantitative MRI in a CADASIL Cohort from Colombia.
    Schoemaker D; Zuluaga Y; Viswanathan A; Shrimer D; Torrico-Teave H; Velilla L; Ospina C; Ospina GG; Lopera F; Arboleda-Velasquez JF; Quiroz YT
    J Int Neuropsychol Soc; 2020 Nov; 26(10):1006-1018. PubMed ID: 32487276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cerebral small vessel disease with delusions in patients with Alzheimer's disease.
    Ogawa Y; Hashimoto M; Yatabe Y; Kaneda K; Honda K; Yuuki S; Hirai T; Ikeda M
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):18-25. PubMed ID: 22396307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Montreal Cognitive Assessment: validity and utility in a memory clinic setting.
    Smith T; Gildeh N; Holmes C
    Can J Psychiatry; 2007 May; 52(5):329-32. PubMed ID: 17542384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.